Implantation of a Continuous-Flow Left Ventricular Assist Device During Cardiopulmonary Bypass Is Associated with a Significant and Transient Acute Thromboinflammatory Response
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27104594 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Alexandra Gerogianni und 12 weiteren Autor:innen. Beteiligte Einrichtung: Linnaeus Centre for Biomaterials Chemistry, Linnaeus University, SE-39182 Kalmar, Sweden. Hauptthemen laut MEDLINE: Heart-Assist Devices, Cardiopulmonary Bypass, Thromboinflammation, Heart Failure. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Research Council of Norway, Swedish Research Council, Knowledge Foundation.
Abstract (Originalsprache)
Left ventricular assist device (LVAD) implantation is a life-saving therapy for end-stage heart failure but may compromise immune integrity. Mechanical shear stress and surface-induced innate immune activation can trigger bleeding and thromboembolic complications. While thrombotic mechanisms are well characterized, the associated inflammatory response remains poorly studied. We investigated thromboinflammation in patients with terminal heart failure (n = 8) implanted with the HeartWare ventricular assist device. Blood samples were collected before and immediately after implantation, daily for five days, and three months post-implantation. Ten age- and sex-matched healthy individuals served as controls. Samples were analyzed for a broad panel of thromboinflammatory and cell damage biomarkers. Twenty-eight of 43 biomarkers were significantly elevated (p < 0.05) at patient baseline compared with controls, indicating a pre-existing low-grade inflammatory state prior to LVAD implantation. Complement activation products increased markedly immediately after implantation—C3bc, C3bBbP, and the terminal complement complex C5b-9 rose 2.8-, 8.9-, and 6.6-fold, respectively, compared with baseline (p < 0.0001), but returned toward baseline within 24 h. A similar transient increase was observed for TNF, IL-6, IL-8, IL-10, IFN-γ, MMP-8, MMP-9, tissue factor, and prothrombin fragment 1.2 (p < 0.05). LVAD implantation with cardiopulmonary bypass induces a strong but transient immune response, including robust complement activation. Targeting upstream complement pathways may help attenuate downstream thromboinflammatory processes during the acute post-implantation period.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Linnaeus Centre for Biomaterials Chemistry, Linnaeus University, SE-39182 Kalmar, Sweden.
- Department of Chemistry and Biomedicine, Linnaeus University, SE-39182 Kalmar, Sweden.
- Department of Cardiothoracic Surgery, Oslo University Hospital, Rikshospitalet, NO-0372 Oslo, Norway.
- Department of Immunology, Oslo University Hospital, University of Oslo, NO-0372 Oslo, Norway.
- Department of Cardiology, Oslo University Hospital, Rikshospitalet, NO-0372 Oslo, Norway.
- Department of Medical Biochemistry, Oslo University Hospital, Rikshospitalet, NO-0372 Oslo, Norway.
ORCID-Profile: Dick J Sjöström, Carola Henriksson, Tom E Mollnes, Per H Nilsson
Förderung
- The Research Council of Norway
- Swedish Research Council
- Knowledge Foundation
- Norwegian Research Council
- Swedish Knowledge Foundation
Zitieren
APA
Gerogianni, A., Sørensen, G., Hoel, T. N., McAdam, K. E., Schjalm, C., Gude, E., Sjöström, D. J., Henriksson, C., Mohlin, C., Barratt-Due, A., Fiane, A., Mollnes, T. E., & Nilsson, P. H. (2026). Implantation of a Continuous-Flow Left Ventricular Assist Device During Cardiopulmonary Bypass Is Associated with a Significant and Transient Acute Thromboinflammatory Response. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27104594
Vancouver
Gerogianni A, Sørensen G, Hoel TN, McAdam KE, Schjalm C, Gude E, et al. Implantation of a Continuous-Flow Left Ventricular Assist Device During Cardiopulmonary Bypass Is Associated with a Significant and Transient Acute Thromboinflammatory Response. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27104594
BibTeX
@article{Gerogianni2026,
author = {Gerogianni, Alexandra and Sørensen, Gro and Hoel, Tom Nilsen and McAdam, Karin E and Schjalm, Camilla and Gude, Einar and Sjöström, Dick J and Henriksson, Carola and Mohlin, Camilla and Barratt-Due, Andreas and Fiane, Arnt and Mollnes, Tom E and Nilsson, Per H},
title = {Implantation of a Continuous-Flow Left Ventricular Assist Device During Cardiopulmonary Bypass Is Associated with a Significant and Transient Acute Thromboinflammatory Response},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27104594}
}
EUVIMED